Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Zepbound for Chronic Weight Management As of November 2023, Zepbound has been approved by the FDA for chronic weight management
Your provider can document your BMI, health history, previous weight-loss efforts, and medical necessity and submit this documentation directly to Anthem
The agreed prices will come into effect no later than January for cash payers, by mid-2026 for Medicare patients and on an ongoing basis for Medicaid enrollees, depending on when states sign up
Growth hormone-releasing hormone analogs, such as tesamorelin, sermorelin, and CJC-1295, stimulate the pituitary to release growth hormone in a pattern closer to natural pulsatile secretion than injected human growth hormone produces
Keep the medication in its original container and away from moisture and heat
Choose retatrutide if Maximum weight loss is the priority
